Pharmacy News

Hospira Recalls 0.5% Marcaine 30-mL Vials

Cheryl A. Thompson

BETHESDA, MD 18 Jun 2014—Hospira Inc. on June 17 announced the recall of 0.5% Marcaine lot 33-545-DDExternal Link because of a confirmed report of particulates in the drug solution and embedded in the glass vial.

Vials in the lot contain 30 mL of preservative-free bupivacaine hydrochloride injection.

The company attributed the particulate embedded in the vial to defective glass provided by a supplier.

Vials in lot 33-545-DD were distributed from November 2013 through March 2014, Hospira said.

Direct customers of Hospira should expect to receive a letter about the recall and return of vials in lot 33-545-DD. The company said anyone with a vial from lot 33-545-DD should quarantine and not use it. Questions about the recall process should be directed to Stericycle at 888-656-6380, Monday–Friday 8 a.m. to 5 p.m. Eastern Time.

Hospira did not identify the particulates in the Marcaine glass vial. But in a recall earlier this year of generic preservative-free 0.5% bupivacaine in 30-mL glass vialsExternal Link, the company said it had identified the embedded particulates as iron oxide.


Contact Us
For questions, comments, or more information on this article, please contact the ASHP News Center at
ASHP Product Listing